The 17␤-hydroxysteroid dehydrogenase (17␤HSD) enzyme system governs important redox reactions at the C17 position of steroid hormones. Different 17␤HSD types (no. 1-4) have been identified to date in peripheral human tissues, such as placenta, testis, and breast. However, there is little information on their expression and activity in either normal or malignant prostate. In the present work, we have inspected pathways of 17␤-oxidation of either androgen or estrogen in human prostate cancer cells (LNCaP, DU145, and PC3) in relation to the expression of messenger RNAs (mRNAs) for 17␤HSD types 1-4. These cell systems feature distinct steroid receptor status and response to hormones. We report here that high expression levels of 17␤HSD4 were consistently observed in all three cell lines, whereas even greater amounts of 17␤HSD2 mRNA were detected solely in PC3 cells. Neither 17␤HSD1 nor 17␤HSD3 mRNAs could be detected in any cell line. From a metabolic standpoint, intact cell analysis showed a much lower extent of 17␤-oxidation of both androgen [testosterone (T)] and estrogen [estradiol (E 2 )] in LNCaP and DU145 cells compared to PC3 cells, where a greater precursor degradation and higher formation rates of oxidized derivatives (respectively, androstenedione and estrone) were observed. Using subcellular fractionation, we have been able to differentiate among 17␤HSD types 1-4 on the basis of their distinct substrate specificities and subcellular localization. This latter approach gave rise to equivalent results. PC3 cells, in fact, displayed a high level of microsomal activity with a low E 2 /T activity ratio and approximately equal apparent K m values for E 2 and T, suggesting the presence of 17␤HSD2. Dehydrogenase specific activity with both E 2 and T was also detected, although at lower levels, in LNCaP and DU145 cells. No evidence for reductase activity could be obtained in either the soluble or microsomal fraction of any cell line. As comparable expression levels of 17␤HSD4 were seen in the three cell lines, 17␤HSD2 is a likely candidate to account for the predominant oxidative activity in PC3 cells, whereas 17␤HSD4 may account for the lower extent of E 2 oxidation seen in both LNCaP and DU145 cells. This is the first report on the expression of four different 17␤HSD types in human prostate cancer cells. It ought to be emphasized that for the first time, analysis of different 17␤HSD activities in either intact or fractionated cells harmonizes with the expression of relevant mRNAs species. (Endocrinology 138: 4876 -4882, 1997) T HE REDOX reactions at position C17 of the steroid molecule represent a key step in both biosynthesis and metabolism of gonadal steroids, either androgen or estrogen (1, 2). In particular, the 17␤-hydroxysteroid dehydrogenase (17␤HSD) enzyme system presides over important steroid interconversions, including that of testosterone (T), androstenedione (⌬ 4 Ad), estradiol (E 2 ), and estrone (E 1 ). To date at least four different human 17␤HSDs have been identified, their complementary DNAs (cDNAs) cloned, and their amino acid sequences deduced. The soluble 17␤HSD1, consisting of 327 amino acids, was originally isolated from human placenta and performs the oxidation of E 2 at the same efficiency as the reduction of E 1 (3, 4). 17␤HSD2 is a microsomal enzyme of 387 amino acids that slightly favors the oxidation over the reduction of either androgen or estrogen and is expressed at high levels in the human placenta (5, 6). The microsomal 17␤HSD3, which is exclusively expressed in human testis, consists of 310 amino acids and is responsible for the reduction of estrogens and androgens (7). Recently, cDNAs encoding for human, mouse, and porcine 17␤HSD4 have been identified (8 -11). They share 85% amino acid identity and metabolize estrogens and androgens very efficiently, displaying a 400-fold preference for steroid oxidation. A 3-kb messenger RNA (mRNA) codes for peroxisomal 80-kDa (737 amino acids) protein, featuring domains that are absent in the other 17␤HSDs. We have shown that both the 80-kDa and its N-terminal 32-kDa (amino acids 1-323) fragment are able to perform the dehydrogenase reaction not only with steroids at the C17 position, but also with 3-hydroxyacyl coenzyme A (12).
and estrone) were observed. Using subcellular fractionation, we have been able to differentiate among 17␤HSD types 1-4 on the basis of their distinct substrate specificities and subcellular localization. This latter approach gave rise to equivalent results. PC3 cells, in fact, displayed a high level of microsomal activity with a low E 2 /T activity ratio and approximately equal apparent K m values for E 2 and T, suggesting the presence of 17␤HSD2. Dehydrogenase specific activity with both E 2 and T was also detected, although at lower levels, in LNCaP and DU145 cells. No evidence for reductase activity could be obtained in either the soluble or microsomal fraction of any cell line. As comparable expression levels of 17␤HSD4 were seen in the three cell lines, 17␤HSD2 is a likely candidate to account for the predominant oxidative activity in PC3 cells, whereas 17␤HSD4 may account for the lower extent of E 2 oxidation seen in both LNCaP and DU145 cells. This is the first report on the expression of four different 17␤HSD types in human prostate cancer cells. It ought to be emphasized that for the first time, analysis of different 17␤HSD activities in either intact or fractionated cells harmonizes with the expression of relevant mRNAs species. (Endocrinology 138: 4876 -4882, 1997) T HE REDOX reactions at position C17 of the steroid molecule represent a key step in both biosynthesis and metabolism of gonadal steroids, either androgen or estrogen (1, 2) . In particular, the 17␤-hydroxysteroid dehydrogenase (17␤HSD) enzyme system presides over important steroid interconversions, including that of testosterone (T), androstenedione (⌬ 4 Ad), estradiol (E 2 ), and estrone (E 1 ). To date at least four different human 17␤HSDs have been identified, their complementary DNAs (cDNAs) cloned, and their amino acid sequences deduced. The soluble 17␤HSD1, consisting of 327 amino acids, was originally isolated from human placenta and performs the oxidation of E 2 at the same efficiency as the reduction of E 1 (3, 4) . 17␤HSD2 is a microsomal enzyme of 387 amino acids that slightly favors the oxidation over the reduction of either androgen or estrogen and is expressed at high levels in the human placenta (5, 6 ). The microsomal 17␤HSD3, which is exclusively expressed in human testis, consists of 310 amino acids and is responsible for the reduction of estrogens and androgens (7) . Recently, cDNAs encoding for human, mouse, and porcine 17␤HSD4 have been identified (8 -11) . They share 85% amino acid identity and metabolize estrogens and androgens very efficiently, displaying a 400-fold preference for steroid oxidation. A 3-kb messenger RNA (mRNA) codes for peroxisomal 80-kDa (737 amino acids) protein, featuring domains that are absent in the other 17␤HSDs. We have shown that both the 80-kDa and its N-terminal 32-kDa (amino acids 1-323) fragment are able to perform the dehydrogenase reaction not only with steroids at the C17 position, but also with 3-hydroxyacyl coenzyme A (12) .
Evidence for key steroid enzymes in human prostate tis-sues has been repeatedly reported (13, 14) . However, little is known of the expression and function of the different 17␤HSD types in either normal or malignant prostate gland. Most previous studies have used crude extracts of homogenized tissues to compare the activities of steroid enzymes in normal, hyperplastic, and carcinomatous human prostate (15) . Although this in vitro characterization of enzymes (as either purified or expressed proteins) may represent a versatile tool in understanding their potential physiological roles, in vivo conditions (including subcellular localization, pH, concentrations of cofactors and substrates, feedback mechanisms, etc.) may well drive the reactions with different kinetics and oxidation/reduction preferences. This is also reflected in the discrepancies often emerging between estimates of intratissue amounts of individual steroids and the extent of relevant enzyme activities, as measured by crude extract methods. After optimization of liquid chromatographic procedures, we established an original intact cell analysis that allows measurement of several enzyme activities of steroid metabolism in living cultured cells (16 -18) . This in vivo approach, while retaining cells in a physiological microenvironment, enables to use close to physiological amounts of steroid precursors and preserves conversion rates and direction of steroid metabolism, which could be otherwise disturbed by tissue homogenization or simplification to few enzymes in vitro.
In the present work, we have used both intact cell analysis and subcellular fractionation assays to inspect pathways of 17␤-oxidation of androgens and estrogens in human prostate cancer cell lines that feature distinct steroid receptor contents and responses to hormones; these are used as helpful model systems for either hormone-sensitive or refractory prostate cancer. We compared the metabolic conversion rates of cells in culture with the expression of mRNAs for the four types of 17␤HSD identified to date to verify which enzyme(s) is responsible for the observed reactions. The results of these studies are reported herein.
Materials and Methods Chemicals
All chemicals were of analytical grade. [␣-
32 P]deoxy-CTP was obtained from Hartmann Analytic (Braunschweig, Germany).
Cell culture
LNCaP.FGC (passage 19), DU145 (passage 59), and PC3 (passage 17) human prostate cancer cells were obtained from the American Type Culture Collection (Rockville, MD). For routine maintenance, cells were grown in RPMI 1640 medium, supplemented with 10% FCS, 2 mm l-glutamine, and antibiotics (100 IU/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B), at 37 C in a humidified atmosphere of 5% CO 2 in air. Cells were periodically tested for mycoplasma contamination. For all experiments, the passage number of cells in culture was kept in a narrow range (LNCaP, 22-25; DU145, 63-67; PC3, 19 -23) .
Steroid metabolism
The methodological procedures used to assess patterns of steroid metabolism in in vitro systems were extensively described previously (19 -21) . Cells (0.5-2 ϫ 10 6 ) were plated onto 60-mm cell culture dishes and left undisturbed for 24 -48 h. After two washes in PBS-A (170 mm NaCl, 3.4 mm KCl, and 2 mm Na 2 PO 4 , pH 7.2), the medium was substituted with FCS-free, phenol red-free RPMI medium to avoid interfering factors that might modify the metabolic ability of the cells. After an additional 24 h, medium was replaced with the same medium containing 1 nm radioactive T ( [1,2,6,7- 3 H]T; SA, 92.1 Ci/mmol; DuPont de Nemours Italiana, Milan, Italy) or E 2 ([6,7- 3 H]E 2 ; SA, 48 Ci/mmol; DuPont) used as precursors. Both steroids were periodically checked and purified using HPLC before experimental use. After 24-h incubation, medium was transferred to sterile plastic tubes (Costar, Cambridge, MA) and stored at Ϫ80 C until analysis. For time-course experiments, triplicate dishes (5 ϫ 10 5 cells/dish) were incubated in the presence of 1 nm labeled T for 30 min and 2, 8, and 24 h under exactly the same experimental conditions. Medium and cells were thus processed as described below.
Extraction procedures
Extraction of both conjugate and free steroids was carried out, as previously described (19, 20) , from the incubation medium as it has been shown to contain proportionally greater amounts of radioactive metabolites than those present in the cells (22, 23) . Briefly, medium aliquots (1 ml) were transferred to scintillation vials to assess the total radioactivity. Before any sample manipulation, all glassware was coated with 4 g of the same radioinert steroid to minimize radioactivity losses. Extracts of either conjugate or hydrolyzed steroids were finally dried and stored at Ϫ20 C until chromatographic analysis. 
Chromatographic analysis
The dried extracts were resuspended in 30 l acetonitrile (androgens) or in a mixture consisting of 10 l acetonitrile, 10 l acetic acid (0.2 m), and 10 l equilin (estrogens), with the latter used as internal standard. Twenty microliters of the resulting solution were used for HPLC analysis, while 5 l were measured in a ␤-counter to quantify the radioactivity extracted for each steroid fraction; the extraction efficiency was calculated as reported previously (19) . Extracted steroids were separated under isocratic conditions on HPLC in the reverse phase mode and quantified using an on-line Flo-One/Beta (500TR) three-channel radioactive detector (Camberra Packard, Meriden, CT). All of the chromatographic procedures used have been previously established and optimized in our laboratories (18) . Precursor degradation and formation of metabolic products were expressed either as a percentage of the conversion rates or as femtomoles per ml. Data were normalized for total radioactivity and/or corrected for equal cell numbers when appropriate.
Subcellular fractionation
Cell monolayers were washed twice with PBS-A. Cells were then collected by centrifugation, suspended in 0.04 m potassium phosphate buffer (pH 7.0) containing glycerol (20% vol/vol) and 10 mm EDTA, and gently homogenized by hand in a glass Dounce homogenizer (Kontes Co., Vineland, NJ). Cell homogenates were centrifuged at 1,000 ϫ g for 10 min to remove cell debris and then at 105,000 ϫ g at 4 C for 40 min. The resulting supernatant was saved as the cytosol. The pellet, designated microsome, was suspended in 0.04 m potassium phosphate (pH 7.0) containing 10 mm EDTA but lacking glycerol. Both fractions were stored at 4 C until analysis.
17␤HSD activity
17␤HSD activity was assayed under conditions that differentiate among type 1, 2, 3, and 4 enzymes, as described previously (24) . Briefly, 10-l aliquots of cytosols or microsomes were combined with 10-l aliquots of the reaction mixture to give 0.5 mm NAD, 1.0 m 2) for the measurement of reductase activity. For the determination of apparent K m (K m app ) and apparent maximum velocity (Vm app ), 0.1 m HEPES, pH 7.2, was used for both dehydrogenase and reductase assays. Reactions were run at 37 C and stopped by transferring the reaction mixture to the preadsorbent layer of a TLC plate (Silica Gel HL, Analtech, Newark, DE). After the addition of 30 l of an unlabeled carrier steroid (4.0 mg/ml) in ethanol, the spots were allowed to dry, and the plate was developed in benzene-acetone (4:1, vol/vol). Substrate and product were located by a light spraying with water. After drying, the spots were scraped into 10 ml Ecolumn (ICN Research Products Division, Costa Mesa, CA) for liquid scintillation counting. Specific activity (nanomoles per mg protein/30 min) was calculated from the counts per min recovered in product as a percentage of the total counts per min recovered in substrate and product, as reported previously (25) .
Protein determination
Protein content was measured by the method of Markwell et al. (26) . BSA was used as the standard.
Data analysis
The K m app and Vm app values were estimated according to the graphic method of Cornish-Bowden and Eisenthal (27) .
RNA blotting
Term placenta tissue was collected after normal delivery, and testicular tissue was obtained from patients orchidectomized for prostate cancer. Extraction of mRNA was performed directly from tissues or PBS-washed cells (3 ϫ 10 7 ) using oligo(deoxythymidine) Dynabeads (Dynal, Hamburg, Germany) according to the manufacturer's instructions. Size fractionation of polyadenylase-enriched RNA was achieved by electrophoresis through a 1% (wt/vol) agarose gel, followed by capillary blotting to a Hybond-N membrane (Schleicher and Schuell, Dassel, Germany) (9) .
Blotting procedures were performed in duplicate, using two different sets of cells for any cell line. Loading of mRNA (10 g from cell lines, 3 g from testes, and 5 g from placenta) was checked using ethidium bromide staining and subsequent UV visualization. The membranes were prehybridized in a solution containing 100 g/ml denatured salmon sperm DNA, 50% formamide, 5 ϫ Denhardt's solution, 0.3% SDS, and 6 ϫ SSPE (0.1 ϫ SSPE ϭ 15 mm NaCl, 1 mm sodium phosphate, and 0.1 mm EDTA, pH 7.4; for 12 h at 42 C), and hybridization (in the same solution except without Denhardt's solution) was carried out with ␣-32 P-labeled probes for 16 h at 42 C. Blots were sequentially hybridized with probes for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Clontech, Heidelberg, Germany), four different types of 17␤HSD, and again for GAPDH. The membranes were then washed to a final stringency of 0.1 ϫ SSPE containing 0.3% SDS at 42 C. The blots were exposed to x-ray X-Omat AR film (Eastman Kodak, Rochester, NY) with an intensifying screen for 12 h after quantification of signals by a Fuji BAS 1000 phosphoimager. Before every hybridization the membranes were stripped of bound radioactive DNA three times in 0.001 ϫ SSPE-0.3% SDS (wt/vol) at 80 C. The efficiency of stripping was checked by phosphoimager. Signals for GAPDH remained unchanged after five hybridizations.
Hybridization probes
Specific DNA probes for 17␤HSDs of approximately 600 bases were PCR amplified using cDNA of 17␤HSD1 (provided by Dr. J. Simard), 17␤HSD2 and 17␤HSD3 (provided by Dr. S. Andersson), and 17␤HSD4 (10) as templates. The sequences of the primers used are given in the Table 1 . Pfu DNA polymerase (Stratagene, Heidelberg, Germany), an annealing temperature of 60 C, and 35 cycles were used. To quantify the amounts of mRNA on the blots, a human GAPDH probe (Clontech) consisting of a 1.1-kilobase (kb) EcoR I/XhoI fragment of GAPDH cDNA was employed. The probes were labeled with a random hexanucleotide Prime-It RmT Kit (Stratagene) and had specific activities greater than 10 9 cpm/g DNA.
Results
Inspection of 17␤HSD oxidative activity was firstly carried out using intact cell analysis through incubation of cultured cells with physiological amounts of a labeled steroid precursor. The reliability of the data was strengthened by the high extraction efficiency and recovery of radioactivity values (Ͼ90% in either case).
The results obtained revealed that either androgen (T) or estrogen (E 2 ) oxidation was remarkably and consistently different in the three cell lines studied (see Fig. 1 ). As far as T metabolism is concerned (Table 2) , PC3 cells showed large precursor degradation (Ͻ2% unconverted T after 24 h) to yield marked amounts (Ͼ70%) of ⌬ 4 Ad and its derivatives of the 17-keto series, 5␣-androstenedione (5␣Adione), androsterone, and epiandrosterone (in total, ϳ25%). In contrast, both LNCaP and DU145 cells gave rise to limited T conversion rates into ⌬ 4 Ad, with the latter never exceeding 5% of all radioactive androgens. Peculiarly, the formation of dihydrotestosterone (DHT) and its derivatives 3␣-and 3␤-androstenediols (3␣/3␤-diols) varied greatly in the three cell lines. In time-course experiments, PC3 cells did not show measurable DHT or 3␣/3␤-diol production at any incubation time, whereas the prevalence of the oxidative pathway leading to ⌬ 4 Ad formation was confirmed (see Fig. 2A ). In fact, T was increasingly converted into ⌬ 4 Ad; an appreciable amount (Ͼ8%) of this metabolite was found after only 30-min incubation. A proportional increase in 5␣Adione was also seen at 8 and 24 h. Formation of ⌬ 4 Ad plus 5␣Adione was inversely and significantly related to the proportion of metabolized T (r ϭ Ϫ0.9706; P Ͻ 0.03, by Spearman correlation test). In contrast, the time course of T metabolism in both LNCaP and DU145 cells revealed low T degradation rates (Ͻ8% and Ͻ18%, respectively). Overall, ⌬ 4 Ad formation did not exceed 5%, whereas relatively greater amounts of both DHT and 3␣/3␤-diols were found in DU145 cells (in total, nearly 15%) with respect to LNCaP cells (only 2%; see Fig. 2 , B and C).
As shown in Table 3 , oxidation of E 2 to E 1 was strikingly greater in PC3 cells (nearly 92% by 24 h) than in LNCaP (14%) or DU145 (7%) cells. The proportion of undegraded precursor (E 2 ) at 24 h ranged from 81-94% in LNCaP and DU145 cells, whereas it remained below 4% in PC3 cells. A small proportion of 16␣-hydroxy-E 1 was also seen in either LNCaP (2.4%) or PC3 (3.8%) cells, whereas small amounts of 2-methoxy-E 2 were found in LNCaP cells only. Likewise for T, time-course experiments reinforced 24-h data on estrogen metabolism; an increasingly greater extent of E 2 oxidation into E 1 was seen in PC3 cells over time (not shown).
Subcellular fractions were assayed for 17␤HSD activity under conditions that differentiate among 17␤HSD types 1, 2, 3, and 4 (28) . The highest level of activity with both E 2 and T was detected in microsomes from PC3 cells. The E 2 /T activity ratio was approximately 1 (see Table 4 ). The K m app and Vm app values were comparable, as were the K m app / Vm app ratios (Table 5 ). 17␤HSD activity with E 2 and T was detected in the other cell lines as well, but at a lower level. Dehydrogenase specific activity for both E 2 and T was highest in the microsomal fraction from LNCaP cells. The cytosolic and microsomal specific activities of DU145 cells were comparable, being the lowest among the three cell lines.
Expression of transcripts for 17␤HSD types 1-4 was scrutinized using Northern blot analysis of cellular mRNA under stringent conditions. Cells were kept under exactly the same experimental conditions as those used to measure 17␤HSD activity and then subjected to mRNA isolation. The fast isolation procedure and the relatively high amounts of mRNA (10 g) used ensured low detection limits; meanwhile, equal lengths of hybridization probes allowed for a direct comparison of the expression levels of the mRNAs. Human testis and placenta tissues provided mRNA for positive controls.
As shown in Fig. 3A , remarkable expression levels of 17␤HSD2 mRNA were seen in PC3 cells, whereas no signal for 17␤HSD2 was revealed in either LNCaP or DU145 cells; this could not be due to uneven loading of mRNAs on the blots, as excluded by either UV visualization of ethidium bromide-stained gels or quantification at laser densitometry of GAPDH signals. In addition, all three cell lines expressed comparable and significant amounts of a 2.9-kb mRNA species for 17␤HSD4. In the same experiments, substantial amounts of 17␤HSD1 and 17␤HSD3 were detected in placenta and testes, respectively. However, neither 17␤HSD1 nor 17␤HSD3 mRNAs could be detected in any cell line, not even after exposure of blots for 1 week (not shown). Duplicate experiments gave rise to the same results.
Densitometric estimates of relative signal intensities after normalization for GAPDH are illustrated in Fig. 3B . As can be seen, LNCaP cells expressed abundant 17␤HSD4 mRNA, whereas lower levels were found in DU145 and, especially, PC3 cells. In the latter, the amounts of 17␤HSD2 mRNA were nearly twice as high as those observed for 17␤HSD4.
Discussion
Data from previous studies on 17␤HSD expression in human prostate tissues and cells have been sparse and even inconsistent. In a recent paper, Pylkkanen and colleagues (29) reported that both newborn and adult human prostate weakly stained for 17␤HSD1, and that its NADPH-dependent reductase activity was present in cell-free homogenates of prostate tissues. By contrast, other investigators failed to detect 17␤HSD1 mRNA in primary cultures of benign prostatic hyperplasia and prostate cancer tissues (30) . The researchers found that prostate cultured epithelial cells and, to a lesser extent, fibroblasts express appreciable amounts of 17␤HSD2 transcript, whereas it was undetectable in prostate tissue homogenates. Equally, the presence of a 2.2-kb mRNA species coding for 17␤HSD2 has been previously reported in the human prostate (31) . This observation is also in accordance with the results of Wu et al. (5) .
We have investigated the expression and activity of 17␤HSDs in cultured human prostate cancer cells (PC3, LNCaP, and DU145). These cell lines have been previously characterized in our laboratories for their growth response to both androgen and estrogen as well as for their respective receptor contents. In particular, LNCaP cells contain both androgen and estrogen receptors; their proliferative activity is significantly stimulated by either steroid (32, 33) . In contrast, androgen receptor-negative PC3 cells and DU145 cells fail to respond to androgens; this despite DU145 cells retain high affinity sites and apparently intact capacity for androgen binding (32) .
In the present work we have seen remarkable expression of 17␤HSD2 in androgen-nonresponsive PC3 cells, whereas no specific mRNA could be detected in DU145 or in hormone-responsive LNCaP cells. On the other hand, no specific transcript for 17␤HSD1 (1.3 or 2.3 kb) or 17␤HSD3 (ϳ1.3 kb) was found in any cell line, even after long exposure of blots, thus confirming previous reports. The authenticity of these observations is proven by strong parallel hybridization signals in placenta (17␤HSD1) and testes (17␤HSD3). Although 17␤HSD1 and -2 could be detected in many tissues (6, 7, 31) , 17␤HSD3 was observed only in testis (5) . High levels of 17␤HSD4 were seen in all three cell lines studied; the amounts of mRNA were comparable to those we previously observed in kidney and much greater than those in placenta or normal prostate (10) . Recent studies on 17␤HSD4 expression in porcine testis have localized the enzyme in peroxisomes of Leydig cells (34) . As the expression levels of 17␤HSD4 are comparable in the three cell lines, 17␤HSD2 is a likely candidate for the predominant oxidative activity seen in PC3 cells. 17␤HSD4 may be of minor importance in this respect, but it may account for the lesser extent of E 2 oxidation observed in both LNCaP and DU145 cells. As the latter cell lines did not express detectable 17␤HSD2 mRNA, the enzymatic activity responsible for T oxidation remains to be identified.
From a metabolic standpoint, striking differences emerged in the extent of 17␤-oxidation of both androgen (T) and estrogen (E 2 ) using intact cell analysis; the extent of reaction was, in fact, significantly greater in PC3 cells, lower in LNCaP cells, and very low DU145 cells. This evidence was repro- The values are the mean (ϮSE) of duplicate assays. Reaction mixtures containing 0.08 M bicine (pH 9.0), 0.5 mM NAD, and 1.0 M steroid substrate were incubated at 37°C for 60 min (microsome) or 180 min (cytosol). ducible and consistent for both T and E 2 metabolism. It is worth mentioning that the large E 2 oxidation seen in PC3 cells combines with the formation of 16␣-hydroxy-E 1 , exactly as we have observed in other hormone-unresponsive human cancer cell lines, in which production of this estrogen derivative is much enhanced by FCS or its major component albumin (35) .
The assay conditions used in this study for estimating 17␤HSD activity on cell homogenates differentiate among the four 17␤HSD types on the basis of their differing substrate specificities and subcellular localization (28) . 17␤HSD1 is a cytosolic enzyme with an E 2 /T activity ratio of approximately 100 (25) . In contrast, 17␤HSD2 is a microsomal enzyme with an E 2 /T activity ratio of approximately 1 (5). For PC3 cells, the high level of microsomal activity compared with cytosol, the low E 2 /T activity ratio, and the approximately equal K m app values for E 2 and T are consistent with the presence of type 2 17␤HSD. Although less than that of PC3 cells, a significant level of activity with E 2 and T was detected in microsomes from LNCaP cells. The low E 2 /T activity ratio is suggestive of the presence of 17␤HSD2. However, the absence of type 2 17␤HSD mRNA and the detection of mRNA for the type 4 isoform suggest that this low ratio may be misleading. It is noteworthy in this regard that 17␤HSD4 is highly specific for E 2 , with little or no affinity for T (10) . The presence of a high level of 17␤HSD4 mRNA in LNCaP and DU145 cells suggests that the microsomal dehydrogenase activity found with E 2 may be due to the type 4 enzyme. A comparable level of microsomal activity with T in the absence of 17␤HSD2 mRNA raises the interesting possibility of the presence in these cancer cells of an as yet unidentified enzyme reactive with T.
To our knowledge, this is the first report on the expression of the four different 17␤HSD types in human prostate cancer cells. Furthermore, for the first time, in vivo measurement of 17␤HSD activity harmonizes with the amounts of relevant 17␤HSD transcripts, as demonstrated by Northern blot analysis. The apparent lack of both type 1 and 3 enzyme transcripts, precluding any reductive activity by 17␤HSD enzymes, deserves a deeper scrutiny, using more sensitive assays for specific mRNAs and proteins.
All of this evidence would imply that distinct 17␤HSDs may be differently regulated in cells with different sensitivities to sex steroids, eventually leading to a differential accumulation of biologically active hormones. Taking into account the multifarious response to estrogen we have observed in these prostate tumor cells (33, 36) , this could be relevant to both growth and progression of human prostatic carcinoma. Further studies should ascertain whether a prevalent 17␤-oxidation driven by 17␤HSD2 and/or 17␤HSD4 associates with hormone refractory prostate cancer, in vivo. FIG. 3 . Distribution of mRNAs for human 17␤HSD. A. Northern blotting analysis. Polyadenylated RNA isolated from human tissues (testis, 3 g; placenta, 5 g) and prostate cancer cell lines (10 g) was subjected to electrophoresis in the presence of formaldehyde and blotted to a nylon membrane that was sequentially hybridized as indicated to the left. Specific 32 P-labeled probes of 600 bp, corresponding to the most N-terminal parts of 17␤HSD1 to -4 enzymes, were amplified with PCR. Human GAPDH probe, consisting of a 1.1-kb EcoR I/HindIII fragment of GAPDH cDNA, was used to quantify the amounts of mRNA on the blots. The molecular mass of the observed RNA is given to the right. B. Signal quantification. After each hybridization, the membranes were subjected to quantification of signals using a Fuji BAS 1000 phosphoimager. Signal intensities are given after normalization to GAPDH levels.
